Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Andrews

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Applied Spectroscopy|September 12, 2018
Quantitative In Situ Monitoring of Parahydrogen Fraction Using Raman SpectroscopyAndrew J Parrott, Paul Dallin, John Andrews, et al.
Molecular Cancer Therapeutics|January 24, 2007
Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinomaTamantha K Stutchbury, Fares Al-Ejeh, Gillian E Stillfried, et al.
Rheumatology and Therapy|February 9, 2018
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc AnalysisRoy Fleischmann, Jürgen Wollenhaupt, Stanley Cohen, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
1,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitorsShawn Maddaford, Paul Renton, Joanne Speed, et al.
Journal of Clinical Gastroenterology|August 3, 2020
Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease TreatmentsScott D Lee, Raina Shivashankar, Daniel Quirk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable regionKalliopi Skamaki, Stephane Emond, Matthieu Chodorge, et al.
Chemical Communications (Cambridge, England)|December 13, 2024
Calibration free approaches for rapid polymorph discrimination <i>via</i> low frequency (THz) Raman spectroscopyMagdalene W S Chong, Martin R Ward, Catriona McFarlan, et al.
Arthritis Research & Therapy|October 23, 2019
Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritisPhilip G Conaghan, Mikkel Østergaard, Orrin Troum, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 26, 2006
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized studyThomas D Schiano, Michael Charlton, Zobair Younossi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2006
A potent human anti-eotaxin1 antibody, CAT-213: isolation by phage display and in vitro and in vivo efficacySarah Main, Rachel Handy, Jane Wilton, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Applied Spectroscopy|September 12, 2018
Quantitative In Situ Monitoring of Parahydrogen Fraction Using Raman SpectroscopyAndrew J Parrott, Paul Dallin, John Andrews, et al.
Molecular Cancer Therapeutics|January 24, 2007
Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinomaTamantha K Stutchbury, Fares Al-Ejeh, Gillian E Stillfried, et al.
Rheumatology and Therapy|February 9, 2018
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc AnalysisRoy Fleischmann, Jürgen Wollenhaupt, Stanley Cohen, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
1,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitorsShawn Maddaford, Paul Renton, Joanne Speed, et al.
Journal of Clinical Gastroenterology|August 3, 2020
Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease TreatmentsScott D Lee, Raina Shivashankar, Daniel Quirk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable regionKalliopi Skamaki, Stephane Emond, Matthieu Chodorge, et al.
Chemical Communications (Cambridge, England)|December 13, 2024
Calibration free approaches for rapid polymorph discrimination <i>via</i> low frequency (THz) Raman spectroscopyMagdalene W S Chong, Martin R Ward, Catriona McFarlan, et al.
Arthritis Research & Therapy|October 23, 2019
Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritisPhilip G Conaghan, Mikkel Østergaard, Orrin Troum, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 26, 2006
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized studyThomas D Schiano, Michael Charlton, Zobair Younossi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2006
A potent human anti-eotaxin1 antibody, CAT-213: isolation by phage display and in vitro and in vivo efficacySarah Main, Rachel Handy, Jane Wilton, et al.
Pageof 10